NEC
Lawsuits related to NEC formulas are gaining attention as a growing concern in the legal sphere concerning product liability. The primary focus of these legal actions revolves around two major baby formula manufacturers, Similac and Enfamil, which collectively hold about 40% of the US infant formula market. These companies face accusations of producing cow’s milk-based formulas that may heighten the risk of premature infants developing Necrotizing Enterocolitis (NEC).
Learn If Your Case Is Eligible
Diving into a legal battle against a giant corporation may seem impossible, especially if you are dealing with illness. TortSource is here to make this journey as stress-free as possible for you, starting with a no-cost case review to answer all your questions and determine if you may qualify for a settlement.
🔒 All information is secure and will never be released
By providing your cell number you acknowledge and consent to receive and exchange communications via text messaging (SMS) and receive automated text messages and/or to receive and exchange communications via an automated telephone dialing system. Messaging and data rates may apply. Text “stop” to opt out at any time. No purchase necessary.
How It Works
Fill out the form or call us toll-free at 855-942-3317. We’ll be in touch within hours to hear your story, answer your questions, and determine if you may qualify for a settlement.
Allow us to gather key medical records and match you with a trusted legal expert who has won cases like yours.
We handle every aspect of building and fighting your case, so you can focus on living peacefully. You pay nothing if you aren’t awarded a settlement.
There are time deadlines to file a claim.
To discuss your claim immediately, click the “Call Us” button, or dial 855-942-3317
Multiple scientific studies propose that cow’s milk-based formulas may trigger inflammation and excessive bacterial growth in infants’ intestines, leading to Necrotizing Enterocolitis (NEC). The initial study pointing to this potential connection dates back to 1990. Despite these findings, such products continue to be promoted as safe for healthy full-term infants, posing a severe risk when given to premature infants. The absence of warning labels on Enfamil’s product packaging, manufactured by Mead Johnson, further complicates the situation. Despite the FDA’s advice against using cow milk-based formula for premature infants, the absence of explicit warnings on the product can potentially mislead parents, putting manufacturers in a legal spotlight. Lawsuits revolve around allegations of misleading marketing practices and product liability. Parents of affected infants argue that manufacturers of both Enfamil and Similac have not only neglected to caution about potential risks but have also actively marketed their products as beneficial, even distributing free samples to expectant mothers.
